OneSource Specialty Pharma Ltd.

OneSource-Hikma get Saudi FDA nod for generic Ozempic (semaglutide). Partnership aims to scale access in MENA region. Details here.

TPG, a private equity giant, sold 8.84 lakh shares of Onesource Specialty Pharma for Rs 139 crore through an open market transaction. Learn more about the deal and its implications.

OneSource Specialty Pharma's Unit 2 in Bengaluru receives GMP certification from ANVISA, enabling the company to supply pharmaceutical products, including GLP-1s, to the Brazilian market.

Three entities, including promoters of Onesource Specialty Pharma, divested a 6.8% stake for Rs 1,202 crore through open market transactions. Motilal Oswal Mutual Fund and CPT Research & Mgmt Co...

Strides Pharma Science's CDMO arm, OneSource Specialty Pharma, secures Rs 801 crore in pre-listing funding from investors, aiming to accelerate growth and expand operations.

Sebi permits net settlement of funds for FPIs in cash market trades, enhancing efficiency and reducing funding costs. Implementation by Dec 31, 2026.

Check the closing bullion rates in Bengaluru for today. Find the latest gold prices (22Kt & 24Kt) and silver rates per KG.

Investors' wealth plunges by Rs 7.17 lakh crore in three days amid market slump. West Asia tensions, crude oil prices, and IT sector woes weigh.

New Telecom Technology Development Fund (TTDF) with higher outlay expected by October. Rs 540 crore sanctioned to 100+ companies.

EAAA India Alternatives, MV Electrosystems, and Yatayat Corporation India receive Sebi approval for initial public offerings (IPOs).

SBI General Insurance reports 8.6% net profit increase to Rs 553 crore in FY26. Gross direct premium grows 14.5%. Solvency ratio strong at 1.90.

PropShare Celestia units ended over 1% lower on their trading debut on BSE. IPO received 1.33x subscription. Details here.

Sebi permits net settlement of funds for FPIs in cash market trades, enhancing efficiency and reducing funding costs. Implementation by Dec 31, 2026.

Noida International Airport names Nitu Sarma interim CEO after BCAS directive. Sarma replaces Christoph Schnellmann, who joins the Board.

BlueStone Jewellery and Lifestyle reports Rs 31.18 crore net profit in Q4, reversing a previous year loss. Total income rises significantly.